Complete remission of nodular basal cell carcinoma after combined treatment with photodynamic therapy and imiquimod 5% cream

Dermatology Online Journal

Volumn 14, Issue 2, 2008, Pages

  Devirgiliis, Valeria ^a   Panasiti, Vincenzo ^a   Curzio, Michela ^a   Gobbi, Silvia ^a   Rossi, Mariarita ^a   Roberti, Vincenzo ^a   Calvieri, Stefano ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; IMIQUIMOD; AMINOLEVULINIC ACID; AMINOQUINOLINE DERIVATIVE; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; METHYL 5-AMINOLEVULINATE; PHOTOSENSITIZING AGENT;

AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; HUMAN; HUMAN TISSUE; MALE; PHOTODYNAMIC THERAPY; REMISSION; SKIN NODULE; LETTER; MULTIMODALITY CANCER THERAPY; OINTMENT; PHOTOCHEMOTHERAPY; SKIN TUMOR;

AGED, 80 AND OVER; AMINOLEVULINIC ACID; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; COMBINED MODALITY THERAPY; HUMANS; MALE; OINTMENTS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REMISSION INDUCTION; SKIN NEOPLASMS;

EID: 41149166613     PISSN: None     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Tran H, Chen K, Shumack S. Epidemiology and aetiology of basal cell carcinoma. Br J Dermatol. 2003 Nov;149 Suppl 66:50-2
2. Ceilley RI, Del Rosso JQ. Current modalities and new advances in the treatment of basal cell carcinoma International Journal of Dermatology 2006, 45, 489-498
3. Babilas P, Karrer S, Sidoroff A, Landthaler M, Szeimies RM. Photodynamic therapy in dermatology-an update. Photodermatol Photoimmunol Photomed. 2005 Jun;21(3):142-9.
4. Surrenti T, De Angelis L, Di Cesare A, Fargnoli MC, Peris K. Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial. Eur J Dermatol. 2007 Aug 2;17(5):412-415
5. Canti G, De Simone A, Korbelik M. Photodynamic therapy and the immune system in experimental oncology. Photochem Photobiol Sci 2002;1:79-80
6. Matzinger P. The danger model: A renewed sense of self. Science 2002;296:301-305
7. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-252.
8. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993;177: 1199-1204.
9. McInturff JE, Modlin RL, Kim J. The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. J Invest dermatol. 2005;125:1-8.
10. Wolf IH, Kodama K, Cerroni L, Kerl H. Nature of Inflammatory Infiltrate in Superficial Cutaneous Malignancies During Topical Imiquimod Treatment. Am J Dermatopathol 2007;29:237-241.